Login or sign up
For business

Axerion Therapeutics

3.9· 11 reviews
Average ratingAverage
3.9/ 5

Based on 11 reviews

527%
436%
336%
20%
10%
Ask AI

Ask Trustburn about Axerion Therapeutics

Based on 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Deepak Ravikumar
Reviews 1

Axerion Therapeutics has been providing satisfactory products and services. I have been a loyal customer for many years now and I appreciate their commitment to quality. However, there is still room for improvement in terms of customer support. Overall, I am happy with my experience.

Steve Realbuto
Reviews 1

Axerion Therapeutics is doing an average job. I have been using their products for a while now and I must say that they are just okay. There is nothing particularly great or excellent about their products. They are just average. I wish they could improve their quality and customer service. Overall, it's an average experience.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Axerion Therapeutics

Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.

Axerion was established in New Haven to develop and commercialize intellectual property licensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.